Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | KIT |
Variant | T417_D419delinsI |
Impact List | indel |
Protein Effect | gain of function - predicted |
Gene Variant Descriptions | KIT T417_D419delinsI results in the deletion of three amino acids in Ig-like C2-type domain 5 of the Kit protein from amino acids 417 to 419, combined with the insertion of an isoleucine (I) at the same site (UniProt.org). T417_D419delinsI results in constitutive ligand-independent phosphorylation of Kit in cell culture (PMID: 16015387), and therefore, is predicted to lead to a gain of Kit protein function. |
Associated Drug Resistance | |
Category Variants Paths |
KIT mutant KIT act mut KIT T417_D419delinsI KIT mutant KIT exon8 KIT T417_D419delinsI |
Transcript | NM_000222.3 |
gDNA | chr4:g.54723601_54723609delinsATC |
cDNA | c.1249_1257delinsATC |
Protein | p.T417_D419delinsI |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_017008180 | chr4:g.54723601_54723609delinsATC | c.1249_1257delinsATC | p.T417_D419delinsI | RefSeq | GRCh38/hg38 |
XM_017008178 | chr4:g.54723601_54723609delinsATC | c.1249_1257delinsATC | p.T417_D419delinsI | RefSeq | GRCh38/hg38 |
NM_000222.2 | chr4:g.54723601_54723609delinsATC | c.1249_1257delinsATC | p.T417_D419delinsI | RefSeq | GRCh38/hg38 |
NM_000222.3 | chr4:g.54723601_54723609delinsATC | c.1249_1257delinsATC | p.T417_D419delinsI | RefSeq | GRCh38/hg38 |
NM_001385285.1 | chr4:g.54723601_54723609delinsATC | c.1249_1257delinsATC | p.T417_D419delinsI | RefSeq | GRCh38/hg38 |
NM_001093772 | chr4:g.54723601_54723609delinsATC | c.1249_1257delinsATC | p.T417_D419delinsI | RefSeq | GRCh38/hg38 |
XM_017008180.1 | chr4:g.54723601_54723609delinsATC | c.1249_1257delinsATC | p.T417_D419delinsI | RefSeq | GRCh38/hg38 |
XM_017008178.1 | chr4:g.54723601_54723609delinsATC | c.1249_1257delinsATC | p.T417_D419delinsI | RefSeq | GRCh38/hg38 |
NM_001385286.1 | chr4:g.54723601_54723609delinsATC | c.1249_1257delinsATC | p.T417_D419delinsI | RefSeq | GRCh38/hg38 |
NM_001093772.1 | chr4:g.54723601_54723609delinsATC | c.1249_1257delinsATC | p.T417_D419delinsI | RefSeq | GRCh38/hg38 |
NM_001093772.2 | chr4:g.54723601_54723609delinsATC | c.1249_1257delinsATC | p.T417_D419delinsI | RefSeq | GRCh38/hg38 |
NM_000222 | chr4:g.54723601_54723609delinsATC | c.1249_1257delinsATC | p.T417_D419delinsI | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|